EUVIMEDEUVIMED entdecken
Open Access

Comparative features and outcomes of major neurological complications of COVID ‐19

Ettore Beghi iD, Elena Moro iD, Eugenia Irene Davidescu iD, Bogdan Ovidiu Popescu, Oxana Grosu, Franco Valzania, Maria Sofia Cotelli, Gordana Kiteva-Trenchevska, Maria Zakharova, Tibor Kovács iD, Carmel Armon, Waldemar Brola und 18 weitere

European Journal of Neurology · 2023-02 · 30 (2) · 413-433

DOI: 10.1111/ene.15617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 07.12.2022. Verfasst von Ettore Beghi und 29 weiteren Autor:innen. Beteiligte Einrichtung: Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. Hauptthemen laut MEDLINE: COVID-19, Nervous System Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Academy of Neurology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose The aim of this study was to assess the neurological complications of SARS‐CoV‐2 infection and compare phenotypes and outcomes in infected patients with and without selected neurological manifestations.

Methods

The data source was a registry established by the European Academy of Neurology during the first wave of the COVID‐19 pandemic. Neurologists collected data on patients with COVID‐19 seen as in‐ and outpatients and in emergency rooms in 23 European and seven non‐European countries. Prospective and retrospective data included patient demographics, lifestyle habits, comorbidities, main COVID‐19 complications, hospital and intensive care unit admissions, diagnostic tests, and outcome. Acute/subacute selected neurological manifestations in patients with COVID‐19 were analysed, comparing individuals with and without each condition for several risk factors.

Results

By July 31, 2021, 1523 patients (758 men, 756 women, and nine intersex/unknown, aged 16–101 years) were registered. Neurological manifestations were diagnosed in 1213 infected patients (79.6%). At study entry, 978 patients (64.2%) had one or more chronic general or neurological comorbidities. Predominant acute/subacute neurological manifestations were cognitive dysfunction ( N = 449, 29.5%), stroke ( N = 392, 25.7%), sleep–wake disturbances ( N = 250, 16.4%), dysautonomia ( N = 224, 14.7%), peripheral neuropathy ( N = 145, 9.5%), movement disorders ( N = 142, 9.3%), ataxia ( N = 134, 8.8%), and seizures ( N = 126, 8.3%). These manifestations tended to differ with regard to age, general and neurological comorbidities, infection severity and non‐neurological manifestations, extent of association with other acute/subacute neurological manifestations, and outcome.

Conclusions

Patients with COVID‐19 and neurological manifestations present with distinct phenotypes. Differences in age, general and neurological comorbidities, and infection severity characterize the various neurological manifestations of COVID‐19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Nervous System DiseasesFemaleHumansRetrospective StudiesSARS-CoV-2PandemicsProspective StudiesSeizures

Stichwörter der Autor:innen

COVID-19coronavirusneurological complicationsneurology

Autor:innen und Institutionen

  • Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Centre Hospitalier Universitaire de Grenoble, Service de Neurologie, Grenoble Institute of Neurosciences, Grenoble Alpes University, Grenoble, France.
  • Neurology Department, Colentina Clinical Hospital, Bucharest, Romania and Department of Clinical Neurosciences, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
  • Diomid Gherman Institute of Neurology and Neurosurgery, Chișinău, Moldova.
  • Neurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Neurology Unit ASST Valcamonica, Brescia, Italy.

ORCID-Profile: Ettore Beghi, Elena Moro, Eugenia Irene Davidescu, Tibor Kovács, Anne Hege Aamodt, Verena Rass, Raimund Helbok, Claudio L A Bassetti

Förderung

  • European Academy of Neurology

Zitieren

APA

Beghi, E., Moro, E., Davidescu, E. I., Popescu, B. O., Grosu, O., Valzania, F., Cotelli, M. S., Kiteva-Trenchevska, G., Zakharova, M., Kovács, T., Armon, C., Brola, W., Yasuda, C. L., Maia, L. F., Lovrencic-Huzjan, A., de Seabra, M. M. L., Avalos-Pavon, R., Aamodt, A. H., Meoni, S., …, & ENERGY Study Group (2023). Comparative features and outcomes of major neurological complications of COVID ‐19. European Journal of Neurology, 30(2), 413-433. https://doi.org/10.1111/ene.15617

Vancouver

Beghi E, Moro E, Davidescu EI, Popescu BO, Grosu O, Valzania F, et al. Comparative features and outcomes of major neurological complications of COVID ‐19. European Journal of Neurology. 2023;30(2):413-433. doi:10.1111/ene.15617

BibTeX
@article{Beghi2023,
  author = {Beghi, Ettore and Moro, Elena and Davidescu, Eugenia Irene and Popescu, Bogdan Ovidiu and Grosu, Oxana and Valzania, Franco and Cotelli, Maria Sofia and Kiteva-Trenchevska, Gordana and Zakharova, Maria and Kovács, Tibor and Armon, Carmel and Brola, Waldemar and Yasuda, Clarissa Lin and Maia, Luís F and Lovrencic-Huzjan, Arijana and de Seabra, Mafalda Maria Laracho and Avalos-Pavon, Rafael and Aamodt, Anne Hege and Meoni, Sara and Gryb, Victoria and Ozturk, Serefnur and Karadas, Omer and Krehan, Ingomar and Leone, Maurizio A and Lolich, Maria and Bianchi, Elisa and Rass, Verena and Helbok, Raimund and Bassetti, Claudio L A and ENERGY Study Group, ENERGY Study Group},
  title = {Comparative features and outcomes of major neurological complications of COVID ‐19},
  journal = {European Journal of Neurology},
  year = {2023},
  volume = {30},
  number = {2},
  pages = {413--433},
  doi = {10.1111/ene.15617}
}
Kostenlos starten →